{"id":"https://openalex.org/W2087242016","doi":"https://doi.org/10.1016/j.ijid.2014.10.009","title":"A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections","display_name":"A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections","publication_year":2014,"publication_date":"2014-10-30","ids":{"openalex":"https://openalex.org/W2087242016","doi":"https://doi.org/10.1016/j.ijid.2014.10.009","mag":"2087242016","pmid":"https://pubmed.ncbi.nlm.nih.gov/25448332"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijid.2014.10.009","doi":"https://doi.org/10.1016/j.ijid.2014.10.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijid.2014.10.009","pdf_url":"http://www.ijidonline.com/article/S1201971214016555/pdf","source":{"id":"https://openalex.org/S35071406","display_name":"International Journal of Infectious Diseases","issn_l":"1201-9712","issn":["1201-9712","1878-3511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.ijidonline.com/article/S1201971214016555/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110473005","display_name":"William D. O\u2019Riordan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"William O\u2019Riordan","raw_affiliation_strings":["eStudySite, 6367 Alvarado Court, Suite 300, San Diego, CA 92120, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eStudySite, 6367 Alvarado Court, Suite 300, San Diego, CA 92120, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109161729","display_name":"Purvi Mehra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102875","display_name":"Artemis (United States)","ror":"https://ror.org/01bv0ma93","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102875"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Purvi Mehra","raw_affiliation_strings":["Artemis Research Group, 770 Washington Street, Suite 300, San Diego, CA 92103, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Artemis Research Group, 770 Washington Street, Suite 300, San Diego, CA 92103, USA","institution_ids":["https://openalex.org/I4210102875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108539437","display_name":"Paul Manos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Manos","raw_affiliation_strings":["eStudySite, 6367 Alvarado Court, Suite 300, San Diego, CA 92120, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"eStudySite, 6367 Alvarado Court, Suite 300, San Diego, CA 92120, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025178921","display_name":"Jeff Kingsley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeff Kingsley","raw_affiliation_strings":["Southeast Regional Research Group, 5210 Armour Road, Suite 300, Columbus, GA 31904, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southeast Regional Research Group, 5210 Armour Road, Suite 300, Columbus, GA 31904, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109186047","display_name":"Laura E. Lawrence","orcid":"https://orcid.org/0009-0009-0990-5299","observed_orcids":["https://orcid.org/0009-0009-0990-5299"]},"institutions":[{"id":"https://openalex.org/I4210128966","display_name":"Melinta Therapeutics (United States)","ror":"https://ror.org/02e451q69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210128966"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Lawrence","raw_affiliation_strings":["Melinta Therapeutics, Inc., 300 George Street, Suite 301, New Haven, CT 06511, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melinta Therapeutics, Inc., 300 George Street, Suite 301, New Haven, CT 06511, USA","institution_ids":["https://openalex.org/I4210128966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002741035","display_name":"Sue Cammarata","orcid":"https://orcid.org/0000-0002-3796-807X","observed_orcids":["https://orcid.org/0000-0002-3796-807X"]},"institutions":[{"id":"https://openalex.org/I4210128966","display_name":"Melinta Therapeutics (United States)","ror":"https://ror.org/02e451q69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210128966"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sue Cammarata","raw_affiliation_strings":["Melinta Therapeutics, Inc., 300 George Street, Suite 301, New Haven, CT 06511, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melinta Therapeutics, Inc., 300 George Street, Suite 301, New Haven, CT 06511, USA","institution_ids":["https://openalex.org/I4210128966"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5110473005"],"corresponding_institution_ids":[],"apc_list":{"value":2900,"currency":"USD","value_usd":2900},"apc_paid":{"value":2900,"currency":"USD","value_usd":2900},"fwci":7.5707,"has_fulltext":true,"cited_by_count":100,"citation_normalized_percentile":{"value":0.98040795,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"30","issue":null,"first_page":"67","last_page":"73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.5723000168800354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.5723000168800354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.21459999680519104,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11080","display_name":"Surgical site infection prevention","score":0.07569999992847443,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/delafloxacin","display_name":"delafloxacin","score":1.0},{"id":"https://openalex.org/keywords/tigecycline","display_name":"tigecycline","score":1.0},{"id":"https://openalex.org/keywords/complicated-skin-and-skin-structure-infections","display_name":"complicated skin and skin structure infections","score":0.9919999837875366},{"id":"https://openalex.org/keywords/fluoroquinolones","display_name":"fluoroquinolones","score":0.7580000162124634},{"id":"https://openalex.org/keywords/tetracycline","display_name":"tetracycline","score":0.8610000014305115},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6480000019073486},{"id":"https://openalex.org/keywords/clinical-cure-rate","display_name":"clinical cure rate","score":0.746999979019165},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.703000009059906},{"id":"https://openalex.org/keywords/wound-infection","display_name":"wound infection","score":0.6010000109672546},{"id":"https://openalex.org/keywords/cellulitis","display_name":"cellulitis","score":0.7440000176429749},{"id":"https://openalex.org/keywords/abscess","display_name":"abscess","score":0.8140000104904175},{"id":"https://openalex.org/keywords/burn-wound-infection","display_name":"burn wound infection","score":0.4350000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9363247156143188},{"id":"https://openalex.org/C2777027569","wikidata":"https://www.wikidata.org/wiki/Q420595","display_name":"Tigecycline","level":3,"score":0.8307777643203735},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.580512285232544},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5382082462310791},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5148431658744812},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5067277550697327},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4540354907512665},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.431640088558197},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.4234100580215454},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4152635335922241},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38791245222091675},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3796667456626892},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37626516819000244},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.2096199095249176},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000038","descriptor_name":"Abscess","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000078304","descriptor_name":"Tigecycline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002481","descriptor_name":"Cellulitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008911","descriptor_name":"Minocycline","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008911","descriptor_name":"Minocycline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014946","descriptor_name":"Wound Infection","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ijid.2014.10.009","doi":"https://doi.org/10.1016/j.ijid.2014.10.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijid.2014.10.009","pdf_url":"http://www.ijidonline.com/article/S1201971214016555/pdf","source":{"id":"https://openalex.org/S35071406","display_name":"International Journal of Infectious Diseases","issn_l":"1201-9712","issn":["1201-9712","1878-3511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:25448332","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25448332","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:doaj.org/article:81d1298d84aa479ead489fe0bf5dd6c5","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/81d1298d84aa479ead489fe0bf5dd6c5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Infectious Diseases, Vol 30, Iss C, Pp 67-73 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ijid.2014.10.009","doi":"https://doi.org/10.1016/j.ijid.2014.10.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijid.2014.10.009","pdf_url":"http://www.ijidonline.com/article/S1201971214016555/pdf","source":{"id":"https://openalex.org/S35071406","display_name":"International Journal of Infectious Diseases","issn_l":"1201-9712","issn":["1201-9712","1878-3511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310145","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95"},{"id":"https://openalex.org/F4320317006","display_name":"Melinta Therapeutics","ror":"https://ror.org/02e451q69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2087242016.pdf","grobid_xml":"https://content.openalex.org/works/W2087242016.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W258096919","https://openalex.org/W611976593","https://openalex.org/W1963642555","https://openalex.org/W2008399938","https://openalex.org/W2050379189","https://openalex.org/W2101357306","https://openalex.org/W2101650905","https://openalex.org/W2102687519","https://openalex.org/W2104664574","https://openalex.org/W2108433768","https://openalex.org/W2114564587","https://openalex.org/W2120892430","https://openalex.org/W2131316809","https://openalex.org/W2135667820","https://openalex.org/W2137175695","https://openalex.org/W2137677452","https://openalex.org/W2141620414","https://openalex.org/W2144634347","https://openalex.org/W2149247054","https://openalex.org/W2168638566","https://openalex.org/W2314225431"],"related_works":["https://openalex.org/W1970548642","https://openalex.org/W2034482054","https://openalex.org/W6901908058","https://openalex.org/W2135543196","https://openalex.org/W4247571570","https://openalex.org/W2082930475","https://openalex.org/W2395318662","https://openalex.org/W2588021005","https://openalex.org/W2100576336","https://openalex.org/W1966699411"],"abstract_inverted_index":{"BACKGROUND:":[0],"A":[1],"randomized,":[2],"double-blind,":[3],"multicenter":[4],"trial":[5],"was":[6,66,74,169,175,190],"done":[7],"to":[8,42],"compare":[9],"two":[10,117],"doses":[11],"of":[12,72,99,183],"delafloxacin":[13,44,50,108,118,137,147,149,167],"with":[14,18],"tigecycline":[15,56,110,139,152,179],"in":[16,106,115,135,146],"patients":[17],"various":[19],"complicated":[20,184],"skin":[21,185],"and":[22,35,109,138,143,151,163,186,189],"skin-structure":[23,187],"infections":[24,26,188],"(wound":[25],"following":[27],"surgery,":[28],"trauma,":[29],"burns,":[30],"or":[31,55],"animal/insect":[32],"bites,":[33],"abscesses,":[34],"cellulitis).":[36],"METHODS:":[37],"Patients":[38],"were":[39,120,133,160],"randomized":[40],"1:1:1":[41],"receive":[43],"300mg":[45],"intravenous":[46],"(IV)":[47],"every":[48,53,63],"12h,":[49,54],"450mg":[51],"IV":[52,62],"100mg":[57],"IV\u00d71,":[58],"followed":[59],"by":[60,68],"50mg":[61],"12h;":[64],"randomization":[65],"stratified":[67],"infection":[69],"type.":[70],"Duration":[71],"therapy":[73],"5-14":[75],"days.":[76],"The":[77],"primary":[78],"efficacy":[79],"analysis,":[80],"performed":[81],"on":[82],"the":[83,89,96,107,116,136,155,165,170],"clinically":[84],"evaluable":[85],"(CE)":[86],"population":[87],"at":[88,130],"test-of-cure":[90],"(TOC)":[91],"visit":[92,132],"(14-21":[93],"days":[94],"after":[95],"final":[97],"dose":[98],"study":[100],"drug),":[101],"compared":[102],"clinical":[103,127],"response":[104,113],"rates":[105,114,129],"arms.":[111],"Clinical":[112],"arms":[119,140],"also":[121],"compared.":[122],"RESULTS:":[123],"Among":[124],"CE":[125],"patients,":[126],"cure":[128],"TOC":[131],"similar":[134],"(94.3%,":[141],"92.5%,":[142],"91.2%,":[144],"respectively":[145],"300-mg,":[148],"450-mg,":[150],"arms).":[153],"Overall,":[154],"most":[156],"frequent":[157],"adverse":[158],"events":[159],"nausea,":[161],"vomiting,":[162],"diarrhea;":[164],"300-mg":[166],"arm":[168],"best-tolerated":[171],"regimen.":[172],"CONCLUSIONS:":[173],"Delafloxacin":[174],"similarly":[176],"effective":[177],"as":[178],"for":[180],"a":[181],"variety":[182],"well":[191],"tolerated.":[192],"(Clinicaltrials.gov":[193],"NCT":[194],"0719810).":[195]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":12},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}